# FDA Inspection 1103463 - Daniel E. Grosz, MD - September 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/daniel-e-grosz-md/25ccb55f-06cb-4658-96be-6046c9c365d5
Source feed: FDA_Inspections

> FDA Inspection 1103463 for Daniel E. Grosz, MD on September 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1103463
- Company Name: Daniel E. Grosz, MD
- Inspection Date: 2019-09-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/daniel-e-grosz-md/476f2a1f-f225-4ea6-a1a4-0b8f6e51bdee

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c